Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
-
Some patients with cancer suffer cognitive impairment after chemotherapy. A brief, sensitive instrument is required to screen patients for cognitive impairment. In this study, we compare three possible screening instruments. ⋯ CogHealth and Headminder were suitable for NESB patients. The HSCS is not recommended for longitudinal studies with short intervals between testing due to practice effect. There is poor correlation between the patients' perception of their cognitive impairment and the objective tests.
-
Support Care Cancer · Nov 2006
Randomized Controlled TrialA randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.
A randomized, open label with blind assessment, controlled trial was performed to assess efficacy and adverse-event profile of vitamin E, given as supplementation for prophylaxis against cisplatin-induced peripheral neuropathy (CIPN). ⋯ Vitamin E effectively and safely protects patients with cancer from occurrence of cisplatin neurotoxicity.
-
Support Care Cancer · Nov 2006
Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience.
Evaluation of suitability and safety of venous port implantation with catheter insertion via the right internal jugular vein in oncology patients. ⋯ The placement of totally implantable venous ports with catheter insertion via the right internal jugular vein has a high success rate without any early complications. Follow-up also demonstrates a low incidence of late complications requiring port removal.
-
Support Care Cancer · Nov 2006
Financial and family burden associated with cancer treatment in Ontario, Canada.
To determine the financial and family resources burden associated with the treatment of cancer. A questionnaire was developed to determine the direct monthly "out-of-pocket costs" (OOPC), the indirect costs, and the associated perceived family burden. ⋯ These results suggest the financial burden is problematic for 20% of this sample. The caregivers' lost time from work influence this burden, and for 36% of this sample, it amounts to one third of their working days in any given month. Policies and programs to address these gaps are needed.
-
Support Care Cancer · Nov 2006
ReviewThe WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?
Pain is a major problem in the treatment of patients with cancer. This article reviews studies concerning evaluation of patients with cancer pain treated according to The World Health Organization (WHO) analgesic ladder. ⋯ However, the evidence that they provide is insufficient to grant the effectiveness of the WHO guidelines because a controlled clinical trial of this intervention has never been published.